Leïla Bengrine-Lefèvre

Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen

Emeric Limagne, Romain Euvrard, Marion Thibaudin et al. · Cancer Research · 2016 · 256 citations

Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis

Coralie Dorard, Aurélie de Thonel, Ada Collura et al. · Nature Medicine · 2011 · 156 citations · Full text

Oncology, Medicine, Colorectal Cancer +8

Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) – A phase II non-randomised trial

Emmanuel Mitry, Thomas Walter, Éric Baudin et al. · European Journal of Cancer · 2014 · 109 citations

Endocrine Oncology, Surgical Oncology, Oncology +8

Cancer Awareness in Atypical Thrombotic Microangiopathies

Lucie Obéric, M. Buffet, Michaël Schwarzinger et al. · The Oncologist · 2009 · 90 citations · Full text

Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study

Benoist Chibaudel, Franck Bonnetain, Christophe Tournigand et al. · The Oncologist · 2011 · 78 citations · Full text